TissueGen is an established company, developing next generation drug delivery technologies.  We use approved biodegradable polymers for our applications, and harness advanced polymeric formulations to enable the delivery of complex therapeutics, ranging from small molecules to temperature and chemically sensitive biologics.

​

Our portfolio is based on our proprietary encapsulation technology which enables delivery of complex compounds, such as antibodies, cytokines, and growth factors using several distinct delivery formats. 

​

Unlike any other drug delivery technologies, our encapsulation platform enables us to bypass major processing hurdles and provide extended duration of release for large structures- proteins/peptides, highly soluble and heat sensitive drugs.